Journal Article

Intraabdominal tissue concentration of ertapenem

M. Wittau, E. Wagner, V. Kaever, T. Koal, D. Henne-Bruns and R. Isenmann

in Journal of Antimicrobial Chemotherapy

Published on behalf of British Society for Antimicrobial Chemotherapy

Volume 57, issue 2, pages 312-316
Published in print February 2006 | ISSN: 0305-7453
Published online January 2006 | e-ISSN: 1460-2091 | DOI: http://dx.doi.org/10.1093/jac/dki459
Intraabdominal tissue concentration of ertapenem

More Like This

Show all results sharing these subjects:

  • Medical Oncology
  • Critical Care

GO

Show Summary Details

Preview

Objectives: Ertapenem, a class I carbapenem, is approved for the treatment of mild to severe intraabdominal infections, but its in vivo concentrations in intraabdominal tissues are unknown. The purpose of this study was to determine the concentration of ertapenem in intraabdominal tissue.

Patients and methods: After informed consent 48 patients, 23 female and 25 male with a median age of 58 years (34–81), requiring surgical intervention at intraabdominal organs were enrolled. Patients received 1 g of ertapenem intravenously for perioperative prophylaxis. Tissue samples were taken after resection of parts of the organs. Plasma samples were taken when tissue samples were taken. Drug concentrations were determined by liquid chromatography/mass spectrometry. An ANCOVA test (analysis of covariance) was performed to assess organ-specific differences in ertapenem concentration and penetration ratios.

Results: Mean ± SD ertapenem tissue concentration (mg/kg) was 16.0 ± 8.8 in the gall bladder, 12.1 ± 5.3 in the colon, 7.0 ± 5.7 in the small bowel, 4.5 ± 2.3 in the liver and 3.4 ± 2.9 in the pancreas. The mean tissue/plasma ratio was 0.19 (colon), 0.17 (small bowel), 0.17 (gall bladder), 0.088 (liver) and 0.095 (pancreas). The ANCOVA test revealed statistically significant organ-specific differences in ertapenem tissue concentration in the gall bladder versus liver/pancreas and in tissue penetration for the colon versus liver/pancreas.

Conclusions: These pharmacokinetic results support the assumption that ertapenem is suitable for the treatment of intraabdominal infections.

Keywords: pharmacokinetics; carbapenems; tissue penetration

Journal Article.  2937 words.  Illustrated.

Subjects: Medical Oncology ; Critical Care

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.